CIESP

Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study

M. Walli-Attaei,P. Joseph,A. Rosengren,C. K. Chow,S. Rangarajan,S. A. Lear,K. F. AlHabib,K. Davletov,A. Dans,F. Lanas,K. Yeates,P. Poirier,K. K. Teo,A. Bahonar,F. Camilo,J. Chifamba,R. Diaz,J. A. Didkowska,V. Irazola,R. Ismail,M. Kaur,R. Khatib,X. Liu,M. Mańczuk,J. J. Miranda,A. Oguz,M. Perez-Mayorga,A. Szuba,L. P. Tsolekile,R. Prasad Varma,A. Yusufali,R. Yusuf,L. Wei,S. S. Anand and S. Yusuf. Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020;396(10244):10.1016/s0140-6736(20)30543-2.

Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study Ver más »

Validation of a telephone-administered geriatric depression scale in a hispanic elderly population

P. Carrete,F. Augustovski,N. Gimpel,S. Fernandez,R. Di Paolo,I. Schaffer and F. Rubinstein. Validation of a telephone-administered geriatric depression scale in a hispanic elderly population. J Gen Intern Med. 2001;16(7):10.1046/j.1525-1497.2001.016007446.x.

Validation of a telephone-administered geriatric depression scale in a hispanic elderly population Ver más »

Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis

I. D. Gallos,A. Papadopoulou,R. Man,N. Athanasopoulos,A. Tobias,M. J. Price,M. J. Williams,V. Diaz,J. Pasquale,M. Chamillard,M. Widmer,Ö. Tunçalp,G. J. Hofmeyr,F. Althabe,A. M. Gülmezoglu,J. P. Vogel,O. T. Oladapo and A. Coomarasamy. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. Cochrane Database Syst Rev. 2018;12(12):10.1002/14651858.CD011689.pub3.

Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis Ver más »

Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysis

W. R. Parry Smith,A. Papadopoulou,E. Thomas,A. Tobias,M. J. Price,S. Meher,Z. Alfirevic,A. D. Weeks,G. J. Hofmeyr,A. M. Gülmezoglu,M. Widmer,O. T. Oladapo,J. P. Vogel,F. Althabe,A. Coomarasamy and I. D. Gallos. Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysis. Cochrane Database Syst Rev. 2020;11(11):10.1002/14651858.CD012754.pub2.

Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysis Ver más »

Uses and Applications of Eq-5d in Latin America & the Caribbean: Systematic Review and Bibliometric Analysis

L. Rey-Ares,A. Hernandez-Vasquez,V. Irazola,D. Comande and F. Augustovski. USES AND APPLICATIONS OF EQ-5D IN LATIN AMERICA & THE CARIBBEAN: SYSTEMATIC REVIEW AND BIBLIOMETRIC ANALYSIS. Value in Health. 2017;20(9):10.1016/j.jval.2017.08.2801.

Uses and Applications of Eq-5d in Latin America & the Caribbean: Systematic Review and Bibliometric Analysis Ver más »

Use of kidneys from trypanosoma cruzi-infected donors in naive transplant recipients without prophylactic therapy: the experience in a high-risk area

F. Cicora,V. Escurra,S. Silguero,I. M. González and J. E. Roberti. Use of kidneys from trypanosoma cruzi-infected donors in naive transplant recipients without prophylactic therapy: the experience in a high-risk area. Transplantation. 2014;97(1):10.1097/01.Tp.0000437673.86339.82.

Use of kidneys from trypanosoma cruzi-infected donors in naive transplant recipients without prophylactic therapy: the experience in a high-risk area Ver más »

Use of bortezomib to treat anti-HLA antibodies in renal transplant patients: a single-center experience

F. Cicora,M. Paz,F. Mos and J. Roberti. Use of bortezomib to treat anti-HLA antibodies in renal transplant patients: a single-center experience. Transpl Immunol. 2013;29(1-4):10.1016/j.trim.2013.08.003.

Use of bortezomib to treat anti-HLA antibodies in renal transplant patients: a single-center experience Ver más »

Use of belatacept as alternative immunosuppression in three renal transplant patients with de novo drug-induced thrombotic microangiopathy

F. Cicora,M. Paz,F. Mos and J. Roberti. Use of belatacept as alternative immunosuppression in three renal transplant patients with de novo drug-induced thrombotic microangiopathy. Case Rep Med. 2013;2013:10.1155/2013/260254.

Use of belatacept as alternative immunosuppression in three renal transplant patients with de novo drug-induced thrombotic microangiopathy Ver más »